NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Emobot

Emobot

Private
ParisHealthcare & Life Scienceshttps://emobothealth.com/

Last Round

Accelerator

Apr 16, 2025

Total Funding Raised

$200,000

Company Overview

Emobot is a health technology company that provides a passive, multimodal AI monitoring platform for clinics to detect non-response and relapse in patients with mood disorders.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical AI, Vertical SaaS, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

mental health monitoringpassive monitoringAI mental healthdigital biomarkerremote patient monitoringRPMinterventional psychiatrytreatment-resistant depressionpsychiatry softwareon-device AIdigital therapeuticsDTxaffective computingemotional AIclinician dashboardusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Emobot Comps

Public and private peers based on sector, stage, and business model.

Emobot comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Emobot Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorApr 16, 2025
GrantOct 1, 2022
GrantFeb 3, 2022

Key People

Founding team and executive leadership

Antony Perzo

CTO & Co-founder

Founding Team

Tanel Petelot

CEO & Co-founder

Founding Team

Samuel Lerman

CPO

Executive Team

Emobot Investors

Notable investors and investment history

Emobot investors
InvestorRounds
iPEPS-ICMAccelerator
BpifranceAccelerator
OVHcloud Startup ProgramAccelerator
BpifranceGrant
21st by CentraleSupélecAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors increased 2240% MoM, reaching 19.6K.

  • Aug 22, 2025

    Grew 20% QoQ from 15 to 18 employees.

Emobot Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Emobot Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Emobot's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range14
Year Founded2022
Last FundingApr 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.